IMMUNOMEDICS INC 4
4 · IMMUNOMEDICS INC · Filed Dec 4, 2015
Insider Transaction Report
Form 4
IMMUNOMEDICS INCIMMU
PAETZOLD MARY E
Director
Transactions
- Exercise/Conversion
Common Stock
2015-12-01$1.59/sh+10,000$15,900→ 65,738 total - Exercise/Conversion
Common Stock
2015-12-01+10,664→ 70,140 total - Exercise/Conversion
Stock Options (right to buy)
2015-12-01−10,000→ 0 totalExercise: $1.59Exp: 2015-12-03→ Common Stock, par value $0.01 per share (10,000 underlying) - Award
Stock Options (right to buy)
2015-12-02+28,821→ 28,821 totalExercise: $3.11Exp: 2022-12-02→ Common Stock, par value $0.01 per share (28,821 underlying) - Award
Restricted Stock Units
2015-12-02+14,469→ 14,469 total→ Common Stock, par value $0.01 per share (14,469 underlying) - Tax Payment
Common Stock
2015-12-01$3.17/sh−6,262$19,851→ 59,476 total - Tax Payment
Common Stock
2015-12-01−2,666→ 67,474 total - Exercise/Conversion
Restricted Stock Units
2015-12-01−10,664→ 0 total→ Common Stock, par value $0.01 per share (10,664 underlying)
Footnotes (4)
- [F1]Delivery of common stock upon vesting of restricted stock units granted on December 3, 2014.
- [F2]The number of shares withheld to satisfy the tax withholding obligation of the reporting person upon vesting of Restricted Stock Units is correlated with the reporting person's tax withholding percentage.
- [F3]The stock options are fully vested on the date of grant.
- [F4]Each restricted stock unit represents a contingent right to receive one share of Immunomedics, Inc. common stock. The restricted stock units shall vest upon the earlier of (i) the reporting person's completion of one year of service as a non-employee director from the date of grant, or (ii) the reporting person's continuation in service through the day immediately preceding the next annual stockholders meeting following the date of grant.